Gilead to buy cancer drugmaker Immunomedics for $21 billion – Yahoo Finance

0
9
Gilead to buy cancer drugmaker Immunomedics for $21 billion – Yahoo Finance

The deal provides Gilead access to Immunomedics’ breast cancer treatment drug, Trodelvy, which was granted an accelerated FDA approval in April. Gilead said it would issue a tender offer to buy all the outstanding shares of Immunomedics for $88 per share, re…
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here